Adrienne G Waks
9PUBLICATIONS
68CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (9)
Sort by Publication Date:
|Jul 19, 2024
Subcutaneous vs Intravenous Trastuzumab/Pertuzumab: A Time and Motion Substudy of a Phase II Trial of Adjuvant Trastuzumab/Pertuzumab for Stage I HER2+ Breast Cancer (ADEPT trial).Adrienne G Waks, Emily L Chen, Noah Graham
|Jun 26, 2023
Genomics of ERBB2-Positive Breast Cancer in Young Women Before and After Exposure to Chemotherapy Plus Trastuzumab.Marla Lipsyc-Sharf, Esha Jain, Laura C Collins
|Feb 01, 2022
Somatic and Germline Genomic Alterations in Very Young Women with Breast Cancer.Adrienne G Waks, Dewey Kim, Esha Jain
|May 04, 2021
Impact of HER2 Heterogeneity on Treatment Response of Early-Stage HER2-Positive Breast Cancer: Phase II Neoadjuvant Clinical Trial of T-DM1 Combined with Pertuzumab.Otto Metzger Filho, Giuseppe Viale, Shayna Stein
|Jul 30, 2020
Acquired FGFR and FGF Alterations Confer Resistance to Estrogen Receptor (ER) Targeted Therapy in ER+ Metastatic Breast Cancer.Pingping Mao, Ofir Cohen, Kailey J Kowalski
Pageof 2
Frequent Collaborators
3 joint publications
Nikhil Wagle
3 joint publications
Eric P Winer
2 joint publications
Marla Lipsyc-Sharf
2 joint publications
Lidia Schapira
2 joint publications
Ian E Krop
2 joint publications
Virginia F Borges
2 joint publications
Vandana G Abramson
2 joint publications
Kathryn J Ruddy
2 joint publications
Nancy U Lin
2 joint publications
Utthara Nayar